• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

    8/2/22 10:20:21 AM ET
    $ALIT
    $AMED
    $ARE
    $BLDR
    Real Estate
    Real Estate
    Medical/Nursing Services
    Health Care
    Get the next $ALIT alert in real time by email

    Upgrades

    For Transocean Ltd (NYSE:RIG), Capital One upgraded the previous rating of Equal-Weight to Overweight. Transocean earned $0.10 in the second quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $5.56 and a 52-week-low of $2.32. Transocean closed at $3.22 at the end of the last trading period.

    Raymond James upgraded the previous rating for Tricon Residential Inc (NYSE:TCN) from Outperform to Strong Buy. For the first quarter, Tricon Residential had an EPS of $0.14, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $17.23 and a 52-week-low of $9.33. At the end of the last trading period, Tricon Residential closed at $10.87.

    Credit Suisse upgraded the previous rating for BanColombia SA (NYSE:CIB) from Neutral to Outperform. In the first quarter, BanColombia showed an EPS of $1.92, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $45.98 and a 52-week-low of $26.27. At the end of the last trading period, BanColombia closed at $28.71.

    Raymond James upgraded the previous rating for bluebird bio Inc (NASDAQ:BLUE) from Market Perform to Outperform. For the first quarter, bluebird bio had an EPS of $1.66, compared to year-ago quarter EPS of $3.07. At the moment, the stock has a 52-week-high of $10.74 and a 52-week-low of $2.87. bluebird bio closed at $3.75 at the end of the last trading period.

    According to JP Morgan, the prior rating for TransMedics Group Inc (NASDAQ:TMDX) was changed from Neutral to Overweight. For the second quarter, TransMedics Group had an EPS of $0.41, compared to year-ago quarter EPS of $0.39. The current stock performance of TransMedics Group shows a 52-week-high of $42.00 and a 52-week-low of $10.00. Moreover, at the end of the last trading period, the closing price was at $41.58.

    See all analyst ratings upgrades.

    Downgrades

    According to Scotiabank, the prior rating for Continental Resources Inc (NYSE:CLR) was changed from Sector Outperform to Sector Perform. Continental Resources earned $3.47 in the second quarter, compared to $0.91 in the year-ago quarter. At the moment, the stock has a 52-week-high of $75.49 and a 52-week-low of $44.38. Continental Resources closed at $67.93 at the end of the last trading period.

    According to Maxim Group, the prior rating for Kazia Therapeutics Ltd (NASDAQ:KZIA) was changed from Buy to Hold. The current stock performance of Kazia Therapeutics shows a 52-week-high of $8.79 and a 52-week-low of $1.63. Moreover, at the end of the last trading period, the closing price was at $1.92.

    Northcoast Research downgraded the previous rating for EVO Payments Inc (NASDAQ:EVOP) from Buy to Neutral. In the second quarter, EVO Payments showed an EPS of $0.30, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.86 and a 52-week-low of $21.01. EVO Payments closed at $33.71 at the end of the last trading period.

    According to UBS, the prior rating for Choice Hotels International Inc (NYSE:CHH) was changed from Buy to Neutral. For the first quarter, Choice Hotels Intl had an EPS of $1.03, compared to year-ago quarter EPS of $0.57. The current stock performance of Choice Hotels Intl shows a 52-week-high of $157.00 and a 52-week-low of $108.70. Moreover, at the end of the last trading period, the closing price was at $122.06.

    For Alexandria Real Estate Equities Inc (NYSE:ARE), TD Securities downgraded the previous rating of Buy to Hold. Alexandria Real Estate earned $2.10 in the second quarter, compared to $1.93 in the year-ago quarter. At the moment, the stock has a 52-week-high of $224.33 and a 52-week-low of $130.00. Alexandria Real Estate closed at $164.32 at the end of the last trading period.

    For HSBC Holdings PLC (NYSE:HSBC), Exane BNP Paribas downgraded the previous rating of Outperform to Neutral. HSBC Holdings earned $1.35 in the second quarter, compared to $0.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.61 and a 52-week-low of $29.17. HSBC Holdings closed at $33.44 at the end of the last trading period.

    BTIG downgraded the previous rating for Builders FirstSource Inc (NYSE:BLDR) from Buy to Neutral. For the second quarter, Builders FirstSource had an EPS of $6.26, compared to year-ago quarter EPS of $2.76. At the moment, the stock has a 52-week-high of $86.48 and a 52-week-low of $48.91. Builders FirstSource closed at $73.34 at the end of the last trading period.

    Truist Securities downgraded the previous rating for Woodward Inc (NASDAQ:WWD) from Buy to Hold. Woodward earned $0.64 in the third quarter, compared to $0.74 in the year-ago quarter. The current stock performance of Woodward shows a 52-week-high of $129.12 and a 52-week-low of $87.59. Moreover, at the end of the last trading period, the closing price was at $104.79.

    Berenberg downgraded the previous rating for Four Corners Property Trust Inc (NYSE:FCPT) from Buy to Hold. For the second quarter, Four Corners Property had an EPS of $0.41, compared to year-ago quarter EPS of $0.38. At the moment, the stock has a 52-week-high of $30.13 and a 52-week-low of $24.24. Four Corners Property closed at $28.78 at the end of the last trading period.

    For PerkinElmer Inc (NYSE:PKI), B of A Securities downgraded the previous rating of Buy to Neutral. In the second quarter, PerkinElmer showed an EPS of $2.32, compared to $2.83 from the year-ago quarter. At the moment, the stock has a 52-week-high of $201.05 and a 52-week-low of $130.65. PerkinElmer closed at $160.87 at the end of the last trading period.

    According to William Blair, the prior rating for EVO Payments Inc (NASDAQ:EVOP) was changed from Outperform to Market Perform. For the second quarter, EVO Payments had an EPS of $0.30, compared to year-ago quarter EPS of $0.21. The current stock performance of EVO Payments shows a 52-week-high of $33.86 and a 52-week-low of $21.01. Moreover, at the end of the last trading period, the closing price was at $33.71.

    For Teladoc Health Inc (NYSE:TDOC), Berenberg downgraded the previous rating of Buy to Hold. In the second quarter, Teladoc Health showed an EPS of $0.44, compared to $0.86 from the year-ago quarter. The current stock performance of Teladoc Health shows a 52-week-high of $95.71 and a 52-week-low of $27.38. Moreover, at the end of the last trading period, the closing price was at $36.81.

    According to Cowen & Co., the prior rating for Teladoc Health Inc (NYSE:TDOC) was changed from Outperform to Market Perform. In the second quarter, Teladoc Health showed an EPS of $0.44, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $95.71 and a 52-week-low of $27.38. Teladoc Health closed at $36.81 at the end of the last trading period.

    HC Wainwright & Co. downgraded the previous rating for Otonomy Inc (NASDAQ:OTIC) from Buy to Neutral. Otonomy earned $0.19 in the second quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Otonomy shows a 52-week-high of $2.59 and a 52-week-low of $0.29. Moreover, at the end of the last trading period, the closing price was at $0.29.

    Cowen & Co. downgraded the previous rating for Farfetch Ltd (NYSE:FTCH) from Outperform to Market Perform. In the first quarter, Farfetch showed an EPS of $0.24, compared to $0.22 from the year-ago quarter. The current stock performance of Farfetch shows a 52-week-high of $35.26 and a 52-week-low of $6.52. Moreover, at the end of the last trading period, the closing price was at $8.23.

    DZ Bank downgraded the previous rating for Intel Corp (NASDAQ:INTC) from Hold to Sell. Intel earned $0.29 in the second quarter, compared to $1.28 in the year-ago quarter. The current stock performance of Intel shows a 52-week-high of $56.28 and a 52-week-low of $35.24. Moreover, at the end of the last trading period, the closing price was at $36.96.

    For Snowflake Inc (NYSE:SNOW), BTIG downgraded the previous rating of Buy to Neutral. Snowflake earned $0.08 in the first quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $344.00 and a 52-week-low of $110.27. Snowflake closed at $150.98 at the end of the last trading period.

    For JELD-WEN Holding Inc (NYSE:JELD), Stifel downgraded the previous rating of Buy to Hold. JELD-WEN Holding earned $0.57 in the second quarter, compared to $0.59 in the year-ago quarter. The current stock performance of JELD-WEN Holding shows a 52-week-high of $27.59 and a 52-week-low of $12.12. Moreover, at the end of the last trading period, the closing price was at $15.34.

    For Amedisys Inc (NASDAQ:AMED), UBS downgraded the previous rating of Neutral to Sell. For the second quarter, Amedisys had an EPS of $1.47, compared to year-ago quarter EPS of $1.69. At the moment, the stock has a 52-week-high of $179.91 and a 52-week-low of $101.61. Amedisys closed at $127.87 at the end of the last trading period.

    HC Wainwright & Co. downgraded the previous rating for Kazia Therapeutics Ltd (NASDAQ:KZIA) from Buy to Neutral. The current stock performance of Kazia Therapeutics shows a 52-week-high of $8.79 and a 52-week-low of $1.63. Moreover, at the end of the last trading period, the closing price was at $1.92.

    BMO Capital downgraded the previous rating for Nuvation Bio Inc (NYSE:NUVB) from Outperform to Market Perform. In the first quarter, Nuvation Bio showed an EPS of $0.10, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.88 and a 52-week-low of $2.48. Nuvation Bio closed at $2.49 at the end of the last trading period.

    For Cracker Barrel Old Country Store Inc (NASDAQ:CBRL), Deutsche Bank downgraded the previous rating of Buy to Hold. For the third quarter, Cracker Barrel Old had an EPS of $1.29, compared to year-ago quarter EPS of $1.51. The current stock performance of Cracker Barrel Old shows a 52-week-high of $139.90 and a 52-week-low of $81.87. Moreover, at the end of the last trading period, the closing price was at $96.22.

    According to Evercore ISI Group, the prior rating for Tellurian Inc (AMEX:TELL) was changed from Outperform to In-Line. Tellurian earned $0.14 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Tellurian shows a 52-week-high of $6.54 and a 52-week-low of $2.23. Moreover, at the end of the last trading period, the closing price was at $3.56.

    For Builders FirstSource Inc (NYSE:BLDR), RBC Capital downgraded the previous rating of Outperform to Sector Perform. In the second quarter, Builders FirstSource showed an EPS of $6.26, compared to $2.76 from the year-ago quarter. The current stock performance of Builders FirstSource shows a 52-week-high of $86.48 and a 52-week-low of $48.91. Moreover, at the end of the last trading period, the closing price was at $73.34.

    According to Citigroup, the prior rating for Kodiak Sciences Inc (NASDAQ:KOD) was changed from Neutral to Sell. For the first quarter, Kodiak Sciences had an EPS of $1.83, compared to year-ago quarter EPS of $0.98. At the moment, the stock has a 52-week-high of $90.24 and a 52-week-low of $4.90. Kodiak Sciences closed at $9.55 at the end of the last trading period.

    According to Stifel, the prior rating for Matson Inc (NYSE:MATX) was changed from Buy to Hold. For the second quarter, Matson had an EPS of $9.49, compared to year-ago quarter EPS of $3.71. The stock has a 52-week-high of $125.34 and a 52-week-low of $68.36. At the end of the last trading period, Matson closed at $91.26.

    BTIG downgraded the previous rating for Nuvation Bio Inc (NYSE:NUVB) from Buy to Neutral. Nuvation Bio earned $0.10 in the first quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $8.88 and a 52-week-low of $2.48. At the end of the last trading period, Nuvation Bio closed at $2.49.

    According to Keybanc, the prior rating for TimkenSteel Corp (NYSE:TMST) was changed from Overweight to Sector Weight. In the first quarter, TimkenSteel showed an EPS of $0.92, compared to $0.43 from the year-ago quarter. At the moment, the stock has a 52-week-high of $26.23 and a 52-week-low of $12.67. TimkenSteel closed at $19.72 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    Northland Capital Markets initiated coverage on Plug Power Inc (NASDAQ:PLUG) with a Market Perform rating. The price target for Plug Power is set to $25.00. For the first quarter, Plug Power had an EPS of $0.27, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $32.05 and a 52-week-low of $12.70. Plug Power closed at $21.24 at the end of the last trading period.

    For scPharmaceuticals Inc (NASDAQ:SCPH), Maxim Group initiated coverage, by setting the current rating at Buy. scPharmaceuticals earned $0.28 in the first quarter, compared to $0.26 in the year-ago quarter. The current stock performance of scPharmaceuticals shows a 52-week-high of $6.80 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $4.89.

    With a Neutral rating, JP Morgan initiated coverage on Kyndryl Holdings Inc (NYSE:KD). The price target seems to have been set at $12.00 for Kyndryl Hldgs. Kyndryl Hldgs earned $1.02 in the first quarter, compared to $2.20 in the year-ago quarter. The stock has a 52-week-high of $19.63 and a 52-week-low of $9.10. At the end of the last trading period, Kyndryl Hldgs closed at $10.89.

    With an Overweight rating, JP Morgan initiated coverage on Alight Inc (NYSE:ALIT). The price target seems to have been set at $10.00 for Alight. The current stock performance of Alight shows a 52-week-high of $11.10 and a 52-week-low of $6.31. Moreover, at the end of the last trading period, the closing price was at $7.42.

    With a Buy rating, BTIG initiated coverage on Immunocore Holdings PLC (NASDAQ:IMCR). The price target seems to have been set at $85.00 for Immunocore Hldgs. In the first quarter, Immunocore Hldgs showed an EPS of $0.48, compared to $1.04 from the year-ago quarter. The current stock performance of Immunocore Hldgs shows a 52-week-high of $49.32 and a 52-week-low of $18.43. Moreover, at the end of the last trading period, the closing price was at $44.73.

    UBS initiated coverage on IVERIC bio Inc (NASDAQ:ISEE) with a Buy rating. The price target for IVERIC bio is set to $20.00. In the second quarter, IVERIC bio showed an EPS of $0.41, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $19.34 and a 52-week-low of $8.85. At the end of the last trading period, IVERIC bio closed at $10.51.

    With an Outperform rating, BMO Capital initiated coverage on Constellation Brands Inc (NYSE:STZ). The price target seems to have been set at $290.00 for Constellation Brands. For the first quarter, Constellation Brands had an EPS of $2.66, compared to year-ago quarter EPS of $2.33. The current stock performance of Constellation Brands shows a 52-week-high of $261.52 and a 52-week-low of $207.59. Moreover, at the end of the last trading period, the closing price was at $244.15.

    With a Buy rating, Benchmark initiated coverage on Chesapeake Energy Corp (NASDAQ:CHK). The price target seems to have been set at $137.00 for Chesapeake Energy. At the moment, the stock has a 52-week-high of $105.00 and a 52-week-low of $61.45. Chesapeake Energy closed at $90.42 at the end of the last trading period.

    Benchmark initiated coverage on Stagwell Inc (NASDAQ:STGW) with a Buy rating. The price target for Stagwell is set to $15.00. Stagwell earned $0.11 in the first quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.92 and a 52-week-low of $4.80. Stagwell closed at $6.65 at the end of the last trading period.

    With a Buy rating, Goldman Sachs initiated coverage on Ross Stores Inc (NASDAQ:ROST). The price target seems to have been set at $102.00 for Ross Stores. For the first quarter, Ross Stores had an EPS of $0.97, compared to year-ago quarter EPS of $1.34. The current stock performance of Ross Stores shows a 52-week-high of $115.22 and a 52-week-low of $69.24. Moreover, at the end of the last trading period, the closing price was at $82.30.

    With a Buy rating, Goldman Sachs initiated coverage on Burlington Stores Inc (NYSE:BURL). The price target seems to have been set at $183.00 for Burlington Stores. For the first quarter, Burlington Stores had an EPS of $0.54, compared to year-ago quarter EPS of $2.59. The current stock performance of Burlington Stores shows a 52-week-high of $292.96 and a 52-week-low of $133.28. Moreover, at the end of the last trading period, the closing price was at $150.17.

    With a Neutral rating, Goldman Sachs initiated coverage on TJX Companies Inc (NYSE:TJX). The price target seems to have been set at $70.00 for TJX Companies. For the first quarter, TJX Companies had an EPS of $0.68, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $77.35 and a 52-week-low of $53.69. At the end of the last trading period, TJX Companies closed at $62.65.

    Stephens & Co. initiated coverage on Xperi Holding Corp (NASDAQ:XPER) with a Equal-Weight rating. The price target for Xperi Holding is set to $19.00. For the first quarter, Xperi Holding had an EPS of $0.92, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $19.90 and a 52-week-low of $13.39. At the end of the last trading period, Xperi Holding closed at $16.88.

    With a Buy rating, Stifel initiated coverage on Merus NV (NASDAQ:MRUS). The price target seems to have been set at $38.00 for Merus. Merus earned $0.43 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.37 and a 52-week-low of $13.46. Merus closed at $24.76 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ALIT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALIT
    $AMED
    $ARE
    $BLDR

    CompanyDatePrice TargetRatingAnalyst
    Transocean Ltd (Switzerland)
    $RIG
    2/10/2026$5.25Hold → Sell
    Pareto
    Kyndryl Holdings Inc.
    $KD
    2/10/2026Buy → Neutral
    Guggenheim
    Kyndryl Holdings Inc.
    $KD
    2/9/2026Outperform → Perform
    Oppenheimer
    Kyndryl Holdings Inc.
    $KD
    2/9/2026$16.00Overweight → Underweight
    Analyst
    Alexandria Real Estate Equities Inc.
    $ARE
    2/3/2026$60.00Neutral
    Goldman
    Kyndryl Holdings Inc.
    $KD
    1/27/2026$40.00Sector Outperform
    Scotiabank
    Builders FirstSource Inc.
    $BLDR
    1/20/2026$137.00Overweight → Equal-Weight
    Stephens
    Intel Corporation
    $INTC
    1/20/2026$50.00Reduce → Hold
    HSBC Securities
    More analyst ratings

    $ALIT
    $AMED
    $ARE
    $BLDR
    SEC Filings

    View All

    SEC Form DEFA14A filed by Plug Power Inc.

    DEFA14A - PLUG POWER INC (0001093691) (Filer)

    2/10/26 4:40:06 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    SEC Form 25-NSE filed by Nuvation Bio Inc.

    25-NSE - Nuvation Bio Inc. (0001811063) (Subject)

    2/10/26 2:20:18 PM ET
    $NUVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by HSBC Holdings plc.

    6-K - HSBC HOLDINGS PLC (0001089113) (Filer)

    2/10/26 11:55:13 AM ET
    $HSBC
    Savings Institutions
    Finance

    $ALIT
    $AMED
    $ARE
    $BLDR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lane Amy B gifted 174 shares and bought $7,915 worth of shares (116 units at $68.23), decreasing direct ownership by 3% to 29,007 units (SEC Form 4)

    4 - TJX COMPANIES INC /DE/ (0000109198) (Issuer)

    2/3/26 7:00:03 PM ET
    $TJX
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Large owner Genmab A/S bought $79,098,068 worth of shares (815,444 units at $97.00) (SEC Form 4)

    4 - Merus N.V. (0001651311) (Issuer)

    12/29/25 5:16:48 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALIT
    $AMED
    $ARE
    $BLDR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for IZERVAY issued to IVERIC BIO, INC.

    Submission status for IVERIC BIO, INC.'s drug IZERVAY (ORIG-1) with active ingredient AVACINCAPTAD PEGOL has changed to 'Approval' on 08/04/2023. Application Category: NDA, Application Number: 217225, Application Classification: Type 1 - New Molecular Entity

    8/9/23 8:37:19 AM ET
    $ISEE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALIT
    $AMED
    $ARE
    $BLDR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $750,000,000 of Senior Notes due 2036

    PASADENA, Calif., Feb. 10, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE:ARE) today announced that it has priced a public offering of $750,000,000 aggregate principal amount of 5.25% senior notes due 2036 (the "notes"). Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, BBVA Securities Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securities, Inc. are acting as joint book-running managers in connection with the public offering, an

    2/10/26 6:56:00 PM ET
    $ARE
    Real Estate Investment Trusts
    Real Estate

    TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    ANDOVER, Mass., Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT. Investors interested in listening to the conference call may do so by dialing (800) 7

    2/10/26 4:05:00 PM ET
    $TMDX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Cracker Barrel Welcomes Spring with New Dishes and the Return of Classic Comforts

    Beloved, craveable favorites and thoughtful seasonal additions keep Cracker Barrel feeling like home LEBANON, Tenn., Feb. 10, 2026 /PRNewswire/ -- This spring, Cracker Barrel Old Country Store is welcoming guests in with the comfort they know by heart. As families look for places that still feel warm, familiar and dependable, Cracker Barrel is welcoming them in with a seasonal menu built around returning classics, thoughtful additions, and the country hospitality guests have trusted for generations.   Rooted in classics like the Ham Dinner and Fried Catfish and brightened by new seasonal recipes like the Smoky Southern Salmon, the spring menu underscores Craker Barrel's commitment to flavor

    2/10/26 1:00:00 PM ET
    $CBRL
    Restaurants
    Consumer Discretionary

    $ALIT
    $AMED
    $ARE
    $BLDR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Transocean downgraded by Pareto with a new price target

    Pareto downgraded Transocean from Hold to Sell and set a new price target of $5.25

    2/10/26 11:10:50 AM ET
    $RIG
    Oil & Gas Production
    Energy

    Kyndryl downgraded by Guggenheim

    Guggenheim downgraded Kyndryl from Buy to Neutral

    2/10/26 7:59:41 AM ET
    $KD
    EDP Services
    Technology

    Kyndryl downgraded by Oppenheimer

    Oppenheimer downgraded Kyndryl from Outperform to Perform

    2/9/26 10:17:44 AM ET
    $KD
    EDP Services
    Technology

    $ALIT
    $AMED
    $ARE
    $BLDR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, GC & Corp Sec Hayes James S covered exercise/tax liability with 2,380 shares, decreasing direct ownership by 2% to 93,787 units (SEC Form 4)

    4 - JELD-WEN Holding, Inc. (0001674335) (Issuer)

    2/10/26 5:34:33 PM ET
    $JELD
    Forest Products
    Basic Materials

    EVP, CDIO Meier Matthew covered exercise/tax liability with 1,395 shares, decreasing direct ownership by 2% to 55,647 units (SEC Form 4)

    4 - JELD-WEN Holding, Inc. (0001674335) (Issuer)

    2/10/26 5:26:15 PM ET
    $JELD
    Forest Products
    Basic Materials

    EVP & CHRO Livingston Wendy A. covered exercise/tax liability with 1,987 shares, decreasing direct ownership by 3% to 72,930 units (SEC Form 4)

    4 - JELD-WEN Holding, Inc. (0001674335) (Issuer)

    2/10/26 5:22:37 PM ET
    $JELD
    Forest Products
    Basic Materials

    $ALIT
    $AMED
    $ARE
    $BLDR
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Inc. Appoints Two New Independent Directors

    SANTA ANA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global manufacturer of technology products, including mission systems, radio frequency ("RF") components and RF microwave/microelectronic assemblies, and technologically advanced interconnect solutions, including printed circuit boards ("PCB") and substrates, today announced that, after long and distinguished careers with TTM, Thomas Edman, the Company's former President and Chief Executive Officer and a current Class I member of the Board of Directors (the "Board"), and John Mayer, a current Class III member of the Board, will retire from the Board effective as of May 7, 2026, immediately

    2/2/26 7:00:00 AM ET
    $CACI
    $DCO
    $TTMI
    EDP Services
    Technology
    Military/Government/Technical
    Industrials

    Plug Power Calls on Stockholders to Act Now and Vote in Favor of Proposals at January 29, 2026 Special Meeting

    SLINGERLANDS, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, encourages stockholders to vote their shares ahead of the Company's Special Meeting of Stockholders (the "Special Meeting") scheduled for January 29, 2026. The Special Meeting includes proposals that are critical to supporting the Company's ongoing operations, financial flexibility and long-term growth strategy. The Board of Directors urges stockholders of record as of December 12, 2025 (the "Record Date") to vote their shares in favor of all proposals presented at the Special Meeting. This Special Meeting follows the Company's

    1/27/26 2:14:23 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    JELD-WEN Appoints Jeffrey Embt as Chief Accounting Officer

    CHARLOTTE, N.C., Jan. 5, 2026 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE:JELD), a leading global manufacturer of building products, today announced the appointment of Jeffrey Embt as chief accounting officer, effective immediately. Embt brings more than 20 years of experience in accounting, financial management, external reporting and strategic planning. Most recently, he served as Chief Financial Officer for Proterra LLC. Embt has also held various finance leadership roles at BWX Technologies and Deloitte & Touche LLP. "Jeff's deep expertise in financial reporting, complian

    1/5/26 4:30:00 PM ET
    $JELD
    Forest Products
    Basic Materials

    $ALIT
    $AMED
    $ARE
    $BLDR
    Financials

    Live finance-specific insights

    View All

    TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

    ANDOVER, Mass., Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT. Investors interested in listening to the conference call may do so by dialing (800) 7

    2/10/26 4:05:00 PM ET
    $TMDX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Transocean to Acquire Valaris

    Creates the world's highest-quality, highest-specification offshore drilling fleet Companies to host conference call today at 8 a.m. CT / 9 a.m. ET STEINHAUSEN, Switzerland and HAMILTON, Bermuda, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE:RIG) and Valaris Limited (NYSE:VAL) today announced the signing of a definitive agreement to combine the two companies under which Transocean will acquire Valaris in an all-stock transaction valued at approximately $5.8 billion (all currency in USD). The shareholding percentages of the combined company, on a fully diluted basis1, will be approximately 53% for Transocean and 47% for Valaris. The enterprise value of the pro forma company is a

    2/9/26 7:50:55 AM ET
    $RIG
    $VAL
    Oil & Gas Production
    Energy

    KYNDRYL REPORTS THIRD QUARTER FISCAL 2026 RESULTS

      Revenues for the quarter ended December 31, 2025 total $3.9 billion, pretax income is $91 million, and net income is $57 millionAdjusted EBITDA is $696 million, adjusted pretax income is $168 million, and adjusted net income is $122 millionKyndryl Consult delivers double-digit revenue growth in the quarter and over the last twelve monthsCompany updates fiscal year 2026 outlookCompany announces leadership changes  NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Kyndryl (NYSE:KD), a leading provider of mission-critical enterprise technology services, today released financial results for the quarter ended December 31, 2025, the third quarter of its 2026 fiscal year. 

    2/9/26 7:06:00 AM ET
    $KD
    EDP Services
    Technology

    $ALIT
    $AMED
    $ARE
    $BLDR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alight Inc.

    SC 13D/A - Alight, Inc. / Delaware (0001809104) (Subject)

    12/10/24 4:00:22 PM ET
    $ALIT
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Alight Inc.

    SC 13D/A - Alight, Inc. / Delaware (0001809104) (Subject)

    12/5/24 4:51:02 PM ET
    $ALIT
    Real Estate

    Amendment: SEC Form SC 13G/A filed by scPharmaceuticals Inc.

    SC 13G/A - scPharmaceuticals Inc. (0001604950) (Subject)

    11/15/24 4:06:50 PM ET
    $SCPH
    Biotechnology: Pharmaceutical Preparations
    Health Care